Duo Oncology Inc. — Form D/A

Duo Oncology Inc. of PITTSBURGH, PA, a company, filed a Form D amendment with the SEC on 2026-06-09. The offering totals $3.0M, of which $1.4M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2026-06-09
• Form: D/A
• Accession: 0001843372-26-000004
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $3.0M
• Amount sold: $1.4M
• Remaining: $1.6M
• Minimum investment: $25K
• Investors: 13
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-548506

Issuer

• Name: Duo Oncology Inc.
• CIK: 0001843372
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 218 OAKLAND AVE, PITTSBURGH, PA, 15213
• Phone: 412-709-1659

Officers, directors & promoters (26)

Showing 25 of 26 people.

Other filings by this issuer (5)

More

• CIK 1843372 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search